Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Eva Ostermeier"'
Autor:
Padmapriya Ponnuswamy, Angelika Schröttle, Eva Ostermeier, Sabine Grüner, Paul L Huang, Georg Ertl, Ulrich Hoffmann, Bernhard Nieswandt, Peter J Kuhlencordt
Publikováno v:
PLoS ONE, Vol 7, Iss 1, p e30193 (2012)
BACKGROUND: All three nitric oxide synthase (NOS) isoforms are expressed in atherosclerotic plaques. NOS enzymes in general catalyse NO production. However, under conditions of substrate and cofactor deficiency, the enzyme directly catalyse superoxid
Externí odkaz:
https://doaj.org/article/6130f50884584a54b614dd8202bc7587
Autor:
Ottar Gadeholt, Sebastian Schuh, Hans-Peter Tony, E. Scharbatke, Tobias Wech, Marc Schmalzing, Eva Ostermeier
Publikováno v:
Rheumatology International. 36:1671-1675
Rheumatoid arthritis (RA) is a chronic inflammatory disease leading to joint destruction. Serologically, it can be differentiated according to rheumatoid factor (RF), anti-cyclic citrullinated peptide antibodies (anti-CCP), or both. This differentiat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7554260f5f4af53bbdc8bf77feee2390
https://doi.org/10.1007/s00296-016-3548-6
https://doi.org/10.1007/s00296-016-3548-6
Autor:
Marion Haubitz, Falk Hiepe, Stefan Heitmann, Eva Ostermeier, Julia Holle, Rebecca Fischer-Betz, Svjetlana Lovric, Jörg Henes, Gerd-Rüdiger Burmester, Raoul Bergner, Petra Roll, Thomas Dorner, Martin Aringer, Christof Specker, Andrea Rubbert-Roth, L. Unger, Hans-Peter Tony, Ulf Müller-Ladner, Hendrik Schulze-Koops, Martin Fleck, Ina Kötter
Publikováno v:
The Journal of Rheumatology. 39:2153-2156
Objective.Rituximab (RTX) therapy is a treatment option in patients with refractory antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). We investigated the tolerability and clinical efficacy of RTX in a cohort of patients with ref
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51f7c45138038c3c62414c4188265efc
https://doi.org/10.3899/jrheum.120482
https://doi.org/10.3899/jrheum.120482
Autor:
Peter J. Kuhlencordt, Bernhard Nieswandt, Padmapriya Ponnuswamy, Paul L. Huang, Eva Ostermeier, Sabine Grüner, Ulrich Hoffmann, Angelika Schröttle, Georg Ertl
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 1, p e30193 (2012)
PLoS ONE, Vol 7, Iss 1, p e30193 (2012)
Background: All three nitric oxide synthase (NOS) isoforms are expressed in atherosclerotic plaques. NOS enzymes in general catalyse NO production. However, under conditions of substrate and cofactor deficiency, the enzyme directly catalyse superoxid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d22137934161fc030bc0b581df155a2f
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/13486
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/13486
Autor:
Martin Feuchtenberger, Petra Roll, Stefan Kleinert, Arne Schäfer, Reinhard E. Voll, Eva Ostermeier, Sven Schwab, E. Scharbatke, Hans-Peter Tony
Publikováno v:
Rheumatology international. 32(6)
The objective of this study is to evaluate the vaccination status in rheumatoid arthritis (RA) patients during routine clinical practice, data from a German non-interventional cross-sectional study. In this prospective study, patients with rheumatoid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a98e4cbf10f8c18dfd5fcb447f411e8
https://pubmed.ncbi.nlm.nih.gov/21327432
https://pubmed.ncbi.nlm.nih.gov/21327432